Literature DB >> 25451607

An HLA-G(∗)14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders.

Franca R Guerini1, Elisabetta Bolognesi2, Matteo Chiappedi3, Alessandro Ghezzo4, Maria Paola Canevini5, Martina M Mensi3, Aglaia Vignoli5, Cristina Agliardi2, Michela Zanette2, Mario Clerici6.   

Abstract

HLA-G expressed by the trophoblast ligates KIR molecules expressed by maternal NK cells at the uterine fetal/maternal interface: this interaction is involved in generating immune tolerance during pregnancy. A 14-bp insertion in the HLA-G 3'-UTR associates with significantly reduced levels of both HLA-G mRNA and soluble HLA-G, thus hampering the efficacy of HLA-G-mediated immune tolerance during pregnancy. Because prenatal immune activation is suggested to play an important role in the onset of autistic spectrum disorders (ASD) we performed an in-depth evaluation of HLA-G polymorphisms in a well-characterized cohort of Italian families of ASD children. Results showed that frequency of both homozygous 14bp+/14bp+ genotype and 14bp+ allele was significantly higher in ASD children and their mothers compared to controls (p<0.05 in all cases); analysis of the frequency of transmission of the 14bp+ allele from parents to ASD children and their non-ASD siblings showed that the 14bp+ allele was more frequently transmitted (T) to ASD children, whereas it was preferentially not transmitted (NT) to the non-ASD siblings (overall discrepancy: p=0.02; OR: 2.6, 95% CI: 1.1-6.4). Results herein suggest that HLA-G polymorphisms are associated with ASD development, possibly as a consequence of prenatal immune activation. These data infer that the immune alterations seen in ASD are associated with the maternal-fetal interaction alone, and reinforce the observation that different genetic backgrounds characterize ASD children and their non-ASD siblings.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autistic spectrum disorder; Genetic polymorphism; HLA; HLA-G; Immune activation; Immune system; In utero immunology; KIR; NK cells

Mesh:

Substances:

Year:  2014        PMID: 25451607     DOI: 10.1016/j.bbi.2014.10.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

Review 1.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 2.  The Role of the Immune System in Autism Spectrum Disorder.

Authors:  Amory Meltzer; Judy Van de Water
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

Review 3.  Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review.

Authors:  Ryad Tamouza; Fernanda Volt; Jean-Romain Richard; Ching-Lien Wu; Jihène Bouassida; Wahid Boukouaci; Pauline Lansiaux; Barbara Cappelli; Graziana Maria Scigliuolo; Hanadi Rafii; Chantal Kenzey; Esma Mezouad; Soumia Naamoune; Leila Chami; Florian Lejuste; Dominique Farge; Eliane Gluckman
Journal:  Front Cell Dev Biol       Date:  2022-07-05

4.  Lactobacillus plantarum PS128 and Other Probiotics in Children and Adolescents with Autism Spectrum Disorder: A Real-World Experience.

Authors:  Martina Maria Mensi; Chiara Rogantini; Michele Marchesi; Renato Borgatti; Matteo Chiappedi
Journal:  Nutrients       Date:  2021-06-14       Impact factor: 5.717

5.  Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?

Authors:  Meriem Bennabi; Richard Delorme; José Oliveira; Catherine Fortier; Mohamed Lajnef; Wahid Boukouaci; Jean-Paul Feugeas; François Marzais; Alexandru Gaman; Dominique Charron; Bijan Ghaleh; Rajagopal Krishnamoorthy; Marion Leboyer; Ryad Tamouza
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 6.  Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder.

Authors:  Anthony R Torres; Thayne L Sweeten; Randall C Johnson; Dennis Odell; Jonna B Westover; Patricia Bray-Ward; David C Ward; Christopher J Davies; Aaron J Thomas; Lisa A Croen; Michael Benson
Journal:  Front Neurosci       Date:  2016-10-20       Impact factor: 4.677

Review 7.  Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein.

Authors:  Valeria Dipasquale; Maria Concetta Cutrupi; Laura Colavita; Sara Manti; Caterina Cuppari; Carmelo Salpietro
Journal:  Int J Mol Cell Med       Date:  2017-09-26

8.  Non-classical human leukocyte antigen class I in Tunisian children with autism.

Authors:  Najla Kharrat; Rania Abdelhedi; Imen Gtif; Imen Ayadi; Roberta Rizzo; Daria Bortolotti; Nouha Bouayed Abdelmoula; Farhat Ghribi; Ahmed Rebai; Ines Zidi
Journal:  Cent Eur J Immunol       Date:  2020-07-27       Impact factor: 2.085

Review 9.  Autism Spectrum Disorder from the Womb to Adulthood: Suggestions for a Paradigm Shift.

Authors:  Cristina Panisi; Franca Rosa Guerini; Provvidenza Maria Abruzzo; Federico Balzola; Pier Mario Biava; Alessandra Bolotta; Marco Brunero; Ernesto Burgio; Alberto Chiara; Mario Clerici; Luigi Croce; Carla Ferreri; Niccolò Giovannini; Alessandro Ghezzo; Enzo Grossi; Roberto Keller; Andrea Manzotti; Marina Marini; Lucia Migliore; Lucio Moderato; Davide Moscone; Michele Mussap; Antonia Parmeggiani; Valentina Pasin; Monica Perotti; Cristina Piras; Marina Saresella; Andrea Stoccoro; Tiziana Toso; Rosa Anna Vacca; David Vagni; Salvatore Vendemmia; Laura Villa; Pierluigi Politi; Vassilios Fanos
Journal:  J Pers Med       Date:  2021-01-25

10.  HLA-class II haplotypes and Autism Spectrum Disorders.

Authors:  Meriem Bennabi; Alexandru Gaman; Richard Delorme; Wahid Boukouaci; Céline Manier; Isabelle Scheid; Nassima Si Mohammed; Djaouida Bengoufa; Dominique Charron; Rajagopal Krishnamoorthy; Marion Leboyer; Ryad Tamouza
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.